Breakthrough Israeli technology for treating acute migraine headaches has been found to be more effective than standard-care medications for adolescents, according to a new study published in the Oxford Journal of the American Academy of Pain Medicine.
Nine percent of children and adolescents worldwide suffer from migraines. The affliction has been associated with poor academic performance, reduced school attendance and as having a negative impact on social interaction and quality of life.
Nerivio, a remote electrical neuromodulation (REN) device developed by Netanya-based Theranica, activates the body’s native conditioned pain modulation mechanism to treat headache and other symptoms associated with migraine by stimulating the free nerve endings in the upper arm.
Read more at Jerusalem Post.
{Matzav.com}
דף יומי יומא פ׳ו: גדולה תשובה שמביאה רפאות לעולם Perhaps someone, or some people, distracted תלמידים חכמים from Torah, and repented. So now, this רפואה lets the ת׳׳ח return to their Torah.
Before cannabis was legalized this would grab market share.